Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Stopped early · Phase 3

Conditions studied: Keratoconus, Corneal Ectasia

In brief

The objectives of this study are to evaluate and compare the safety and efficacy of three treatment regimens for corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System in impeding the progression of, and/or reducing maximum corneal curvature.

Key facts

Study ID
NCT01459679
Run by
American-European Congress of Ophthalmic Surgery
People needed
1721
Starts
2012-07-01
Expected to finish
2016-08-01
Last updated by the study team
2018-07-05

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.